Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
70%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
100%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN XLV
SECTOR DRIFT (XLV minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in IXJ |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 10.4% | 7.3% | 7.3% | |
JOHNSON & JOHNSON | 8.8% | 6.2% | 6.2% | |
ABBVIE INC | 7.4% | 5.2% | 5.2% | |
ABBOTT LABORATORIES | 4.9% | 3.5% | 3.5% | |
UNITEDHEALTH GROUP INC | 4.8% | 3.4% | 3.4% |
XLV Overweight Relative to IXJ
ELI LILLY & CO | 3.1% | |
JOHNSON & JOHNSON | 2.6% | |
ABBVIE INC | 2.2% | |
ABBOTT LABORATORIES | 1.5% | |
UNITEDHEALTH GROUP INC | 1.4% | |
MERCK & CO. INC. | 1.3% | |
THERMO FISHER SCIENTIFIC INC | 1.1% | |
INTUITIVE SURGICAL INC | 1.1% | |
AMGEN INC | 1.0% | |
BOSTON SCIENTIFIC CORP | 1.0% |
XLV Underweight Relative to IXJ
ASTRAZENECA PLC | -3.4% | |
NOVARTIS AG | -3.3% | |
ROCHE HOLDING LTD | -3.2% | |
NOVO NORDISK A/S-B | -2.4% | |
SANOFI-AVENTIS | -1.5% | |
ESSILOR INTERNATIONAL | -1.3% | |
CSL LIMITED | -1.2% | |
GSK PLC | -1.2% | |
LONZA GROUP AG-REG | -0.7% | |
DAIICHI SANKYO CO LTD | -0.7% |